Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Immunai

Explore full profile

Mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes

New York City, United StatesFounded 2019Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2026
Headcount 100–500 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Immunai and the history behind them.

At a glance

Founded
2019
Headquarters
New York City, United States
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Latest news

Press, funding announcements and product moves mentioning Immunai.

See all news

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A4 investors entered at this stage

  • Dexcel Pharma
  • Schusterman Foundation
  • Catalio Capital Management
  • Duquesne Family Office

Series B and later9 investors entered at this stage

  • Stanford University
  • Koch Disruptive Technologies
  • Icon Ventures
  • Parker Institute for Cancer Immunotherapy
  • Alexandria Venture Investments
  • Talos
  • 8VC
  • Piedmont Healthcare
  • Massachusetts Institute of Technology

Talent

Book a demo to see the people
Employees mapped 176 incl. 20 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 16 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Immunai employees who went on to found companies, sorted by Dealroom signal score.

PhaseVEst. 2023
Raviv PrylukIsrael
Signal score93
Jimini HealthEst. 2023
Luis VolochUnited States
Signal score88
DermagnostixEst. 2021
Fabian TheisGermany
Signal score81
Santa Ana BioEst. 2021
Danny WellsUnited States
Signal score66
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇮🇱 Israel42%
🇺🇸 United States39.4%
🇨🇿 Czech Republic12%
🇨🇭 Switzerland3.9%
🇩🇪 Germany1.1%
Top 5 of 8 shown
Web traffic by country
6.4K monthly visits
across markets
🇺🇸 United States67.2%
🇮🇳 India18.8%
🇮🇱 Israel12.5%
🇩🇪 Germany1.6%
Top 4 markets shown

Patents

Estimated portfolio value
$90k

3 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Immunai on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Immunai on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles